p.R306W | TCGA-75-5126 | LUAD | TCGA | LPLYHD | LIG_APCC_ABBA_1 | 293:298 | Mutation rewiring degron network | 0.1111 |
p.R306W | TCGA-AP-A051 | UCEC | TCGA | LPLYHD | LIG_APCC_ABBA_1 | 293:298 | Mutation rewiring degron network | 0.1111 |
p.R306W | TCGA-AP-A0LG | UCEC | TCGA | LPLYHD | LIG_APCC_ABBA_1 | 293:298 | Mutation rewiring degron network | 0.1111 |
p.R306W | DO23711 | LUAD | ICGC | LPLYHD | LIG_APCC_ABBA_1 | 293:298 | Mutation rewiring degron network | 0.1111 |
p.R306W | DO41823 | UCEC | ICGC | LPLYHD | LIG_APCC_ABBA_1 | 293:298 | Mutation rewiring degron network | 0.1111 |
p.R306W | DO42673 | UCEC | ICGC | LPLYHD | LIG_APCC_ABBA_1 | 293:298 | Mutation rewiring degron network | 0.1111 |
p.R306W | SIDM00495 | B-Cell Non-Hodgkin's Lymphoma | GDSC | LPLYHD | LIG_APCC_ABBA_1 | 293:298 | Mutation rewiring degron network | 0.1111 |
p.R306W | SIDM01145 | Gastric Carcinoma | GDSC | LPLYHD | LIG_APCC_ABBA_1 | 293:298 | Mutation rewiring degron network | 0.1111 |
p.P429S | TCGA-AC-A23H | BRCA | TCGA | PTPDFE | DEG_SCF_FBW7_2 | 427:432 | Mutation altering degron motif | 0.6752 |
p.P429S | DO2401 | BRCA | ICGC | PTPDFE | DEG_SCF_FBW7_2 | 427:432 | Mutation altering degron motif | 0.6752 |
p.P288T | TCGA-AY-6197 | COAD | TCGA | LPLYHD | LIG_APCC_ABBA_1 | 293:298 | Mutation rewiring degron network | 0.1944 |
p.P288T | DO9956 | COAD | ICGC | LPLYHD | LIG_APCC_ABBA_1 | 293:298 | Mutation rewiring degron network | 0.1944 |
p.R307I | TCGA-DF-A2KU | UCEC | TCGA | LPLYHD | LIG_APCC_ABBA_1 | 293:298 | Mutation rewiring degron network | 0.0833 |
p.R307I | DO223286 | UCEC | ICGC | LPLYHD | LIG_APCC_ABBA_1 | 293:298 | Mutation rewiring degron network | 0.0833 |
p.K301N | TCGA-EO-A22R | UCEC | TCGA | LPLYHD | LIG_APCC_ABBA_1 | 293:298 | Mutation substituting flanking lysine | 0.3611 |
p.K301N | DO42713 | UCEC | ICGC | LPLYHD | LIG_APCC_ABBA_1 | 293:298 | Mutation substituting flanking lysine | 0.3611 |
p.K301R | TCGA-GL-A59R | KIRP | TCGA | LPLYHD | LIG_APCC_ABBA_1 | 293:298 | Mutation substituting flanking lysine | 0.3611 |
p.K301R | DO44525 | KIRP | ICGC | LPLYHD | LIG_APCC_ABBA_1 | 293:298 | Mutation substituting flanking lysine | 0.3611 |
p.T428A | TCGA-V4-A9EQ | UVM | TCGA | PTPDFE | DEG_SCF_FBW7_2 | 427:432 | Mutation altering degron motif | 0.825 |
p.P294L | DO228313 | LICA | ICGC | LPLYHD | LIG_APCC_ABBA_1 | 293:298 | Mutation altering degron motif | 0.6471 |
p.V287F | DO228667 | LICA | ICGC | LPLYHD | LIG_APCC_ABBA_1 | 293:298 | Mutation rewiring degron network | 0.1667 |
p.L442I | DO229026 | LICA | ICGC | PTPDFE | DEG_SCF_FBW7_2 | 427:432 | Mutation rewiring degron network | 0.0556 |
p.A284S | DO231047 | LUSC | ICGC | LPLYHD | LIG_APCC_ABBA_1 | 293:298 | Mutation rewiring degron network | 0.0833 |
p.L442V | SIDM00643 | Non-Cancerous | GDSC | PTPDFE | DEG_SCF_FBW7_2 | 427:432 | Mutation rewiring degron network | 0.0556 |
p.L442V | ACH-002363 | Non-Cancerous | CCLE | PTPDFE | DEG_SCF_FBW7_2 | 427:432 | Mutation rewiring degron network | 0.0556 |
p.R306Q | SIDM00447 | B-Lymphoblastic Leukemia | GDSC | LPLYHD | LIG_APCC_ABBA_1 | 293:298 | Mutation rewiring degron network | 0.1111 |
p.R306Q | ACH-000960 | Leukemia | CCLE | LPLYHD | LIG_APCC_ABBA_1 | 293:298 | Mutation rewiring degron network | 0.1111 |
p.R306Q | REH | haematopoietic and lymphoid tissue | COSMIC | LPLYHD | LIG_APCC_ABBA_1 | 293:298 | Mutation rewiring degron network | 0.1111 |
p.K423R | SIDM00333 | Endometrial Carcinoma | GDSC | PTPDFE | DEG_SCF_FBW7_2 | 427:432 | Mutation substituting flanking lysine | 0.3333 |
p.K423R | ACH-000988 | Endometrial/Uterine Cancer | CCLE | PTPDFE | DEG_SCF_FBW7_2 | 427:432 | Mutation substituting flanking lysine | 0.3333 |
p.K423R | MFE-319 | endometrium | COSMIC | PTPDFE | DEG_SCF_FBW7_2 | 427:432 | Mutation substituting flanking lysine | 0.3333 |
p.R283Q | ACH-000833 | Sarcoma | CCLE | LPLYHD | LIG_APCC_ABBA_1 | 293:298 | Mutation rewiring degron network | 0.0556 |
p.H422Q | ACH-001367 | Neuroblastoma | CCLE | PTPDFE | DEG_SCF_FBW7_2 | 427:432 | Mutation rewiring degron network | 0.1944 |